Deere & Company R&D increased by 5.2% to $583.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $549.00M to $583.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 9.9% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $377.00M | $394.00M | $450.00M | $402.00M | $453.00M | $481.00M | $576.00M | $495.00M | $547.00M | $528.00M | $606.00M | $533.00M | $565.00M | $567.00M | $626.00M | $526.00M | $549.00M | $556.00M | $680.00M | $554.00M | $583.00M |
| QoQ Change | — | +4.5% | +14.2% | -10.7% | +12.7% | +6.2% | +19.8% | -14.1% | +10.5% | -3.5% | +14.8% | -12.0% | +6.0% | +0.4% | +10.4% | -16.0% | +4.4% | +1.3% | +22.3% | -18.5% | +5.2% |
| YoY Change | — | — | — | — | +20.2% | +22.1% | +28.0% | +23.1% | +20.8% | +9.8% | +5.2% | +7.7% | +3.3% | +7.4% | +3.3% | -1.3% | -2.8% | -1.9% | +8.6% | +5.3% | +6.2% |